Edited by
Dean Paxson, Professor of Finance, Manchester Business School.
Description
Real R&D options are among the earliest modelled real options, with now ten primary practical uses: general R&D planning, planning R&D
in stages, evaluating test information, new product development timing, operations, abandonment, risk sharing, market funding, industry
strategy and regulation.
This book was partly motivated by requests to identify and develop real option models for R&D in telecommunications,
petroleum technology and biotechnology. Nine new models cover information and implementation costs, analytical solutions for mean reverting,
or fat tailed revenues, endogenous learning and exogenous and experiential shocks, American sequential options, and innovator advantages.
Four new applications include forward start development options, exploration options, innovation with information costs, and innovator's
real values with changing market share.
R&D directors and researchers will find several uses for these models:
· general R&D planning
· evaluating test information
· new product development timing
· risk sharing
· industry strategy and regulation
Included in series
Quantitative Finance
Audience:
Corporate financiers; CIOs using 'Real Options' in business valuation, research and development analysis; Investment/portfolio managers;
Equity trust/fund managers in researching companies to invest in; Portfolio planners in most financial institutions and investment houses
who need to value companies; Directors of quantitative analysis in corporates, investment banks and venture capitalist houses; Chief
economists in investment houses; Consultants; Actuaries; Risk managers; Regulators and central bankers; MBA graduate students.
